ISAKOS: 2023 Congress in Boston, MA USA

2023 ISAKOS Biennial Congress Paper

 

Surgical Reconstruction or Rehabilitation for Non-Acute and Longstanding ACL Rupture (ACL SNNAP Pragmatic Randomised Controlled Trial)

David J. Beard, MA, MSc, DPhil, FBOA(Hon) FRCS(Hon), Prof., Oxford, Oxfordshire UNITED KINGDOM
Loretta Davies, DPhil, MSc, Oxford, Oxfordshire UNITED KINGDOM
Jonathan Cook, PhD, Oxford, Oxfordshire UNITED KINGDOM
Jose Leal, PhD, Oxford, Oxfordshire UNITED KINGDOM
Heidi Fletcher, MSc, Oxford, Oxon UNITED KINGDOM
Simon G. F. Abram, MA(Oxon) BMBCh FRCS DPhil, Bristol UNITED KINGDOM
Katie Chegwin, BA, Oxford, Oxfordshire UNITED KINGDOM
William Jackson, FRCS(Orth), MD, Oxford UNITED KINGDOM
Nicholas Bottomley, MBBS, FRCS, DPhil, Oxford, Oxon UNITED KINGDOM
Henry Bourke, BSc(Hons), FRCS(Tr&Orth), Amersham UNITED KINGDOM
Andrew James Price, DPhil, FRCS(Orth), Oxford, Oxfordshire UNITED KINGDOM

University of Oxford, Oxford, Oxon, UNITED KINGDOM

FDA Status Not Applicable

Summary

A large multi-centre (29 sites) pragmatic randomised controlled trial of 316 patients showed that, although both interventions can provide benefit, ACL reconstruction provided superior outcome to rehabilitation (and subsequent ACL reconstruction if necessary) in longer standing and non-acute ACL deficient subjects.

Abstract

Background

Anterior cruciate ligament (ACL) rupture is a common debilitating injury giving rise to instability of the knee. A pragmatic trial was designed to confirm the best management strategy between reconstructive surgery or non-surgical treatment for patients with a non-acute ACL injury and persistent symptoms of instability.

Methods

A pragmatic, multi-centre, superiority, randomised controlled trial with two-arm parallel groups and 1:1 allocation in 29 UK secondary care NHS orthopaedic units. Patients were randomly assigned by computer to either 1. ACL surgery (reconstruction) or 2. rehabilitation (physical therapy - but with subsequent ACL reconstruction permitted if instability persisted after treatment). Patients were stratified by site and baseline KOOS4. This “management” trial design with sequential interventions permitted represented normal practice. The primary outcome was the Knee injury and Osteoarthritis Outcome Score (KOOS4) at 18 months post randomisation. Secondary outcomes included complications, return to sport/activity, patient satisfaction and generic health quality of life/knee resource use for health economic evaluation. The principal analyses were ‘intention to treat’ based, with KOOS-4 scores analysed using linear regression.

Findings:
316 patients were recruited between 1st February 2017 and 12th April 2020. KOOS4 mean (standard deviation) scores at 18 months post-randomisation were 73.0 (20.0) in the surgical arm (n=156), and 64.6 (20.0) in the rehabilitation arm (n=160). The adjusted mean difference was 7.90 (95% CI 2.54 to 13.19; p=0.0053) in favour of surgical management. 41% (n=65) of those allocated to rehabilitation underwent subsequent surgery according to protocol within 18 months. 43 patients allocated to surgery did not receive their allocated treatment (28%). There were no differences between groups in surgical complications. Health economic analysis showed that despite higher healthcare costs for surgery, surgical reconstruction was cost effective.

Conclusions

Both treatments provided benefit but early surgical reconstruction, as a management strategy for non-acute longer-standing ACL injured patients with persistent symptoms of instability, was clinically superior and more cost effective in comparison to rehabilitation management with subsequent reconstruction as required. Patients not wishing to undergo surgical reconstruction, or those in a more acute state, can still derive benefit from non-operative care.